Nutex Health (NASDAQ:NUTX) Given New $225.00 Price Target at Maxim Group

Nutex Health (NASDAQ:NUTXFree Report) had its target price lifted by Maxim Group from $100.00 to $225.00 in a research note released on Tuesday morning,Benzinga reports. They currently have a buy rating on the stock.

Separately, Benchmark boosted their target price on shares of Nutex Health from $150.00 to $300.00 and gave the company a “buy” rating in a research report on Thursday, May 15th.

Get Our Latest Stock Report on NUTX

Nutex Health Stock Up 0.6%

Shares of NASDAQ NUTX opened at $177.21 on Tuesday. The company has a market capitalization of $986.35 million, a P/E ratio of -18.88 and a beta of -0.10. Nutex Health has a 52-week low of $4.16 and a 52-week high of $184.28. The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.74 and a current ratio of 1.77. The company’s 50 day moving average price is $107.01 and its 200-day moving average price is $63.58.

Nutex Health (NASDAQ:NUTXGet Free Report) last released its earnings results on Tuesday, May 13th. The company reported $2.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.15) by $2.71. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%. The company had revenue of $211.79 million for the quarter, compared to the consensus estimate of $81.09 million.

Insider Activity at Nutex Health

In other Nutex Health news, CFO Jon Christian Bates acquired 1,000 shares of the stock in a transaction on Tuesday, April 8th. The shares were purchased at an average price of $81.81 per share, for a total transaction of $81,810.00. Following the completion of the acquisition, the chief financial officer now owns 4,888 shares in the company, valued at approximately $399,887.28. This represents a 25.72% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 38.52% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of NUTX. Topline Capital Management LLC acquired a new position in Nutex Health during the fourth quarter worth $5,690,000. American Century Companies Inc. acquired a new position in Nutex Health during the fourth quarter worth $1,362,000. Ancora Advisors LLC acquired a new position in Nutex Health during the fourth quarter worth $1,334,000. Drive Wealth Management LLC acquired a new position in Nutex Health during the fourth quarter worth $1,122,000. Finally, Essex Investment Management Co. LLC raised its holdings in Nutex Health by 45.4% during the fourth quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company’s stock worth $3,353,000 after buying an additional 33,024 shares during the last quarter. Institutional investors and hedge funds own 5.32% of the company’s stock.

Nutex Health Company Profile

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Recommended Stories

Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.